Crossref
The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer
Oncomedicine · 2017
DOI: 10.7150/oncm.21071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Masahiko Tanabe und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tanabe, M., Fukuda, T., & Ito, Y. (2017). The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer. Oncomedicine. https://doi.org/10.7150/oncm.21071
Vancouver
Tanabe M, Fukuda T, Ito Y. The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer. Oncomedicine. 2017. doi:10.7150/oncm.21071
BibTeX
@article{Tanabe2017,
author = {Tanabe, Masahiko and Fukuda, Takayo and Ito, Yoshinori},
title = {The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer},
journal = {Oncomedicine},
year = {2017},
doi = {10.7150/oncm.21071}
}
EUVIMED